Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DR26FSBZ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,295
Award facts
- Contract value 100% obligated
- $83,294.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83,294.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. The award was issued on November 17, 2025, with an ultimate completion date of December 9, 2025, and includes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy. The underlying IDC, awarded on November 13, 2025, establishes DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. The contract structure includes a 30-month base period with three 30-month option periods extending through December 31, 2036, positioning the contractor as a key supplier within the federal pharmaceutical supply chain for defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FSBZ8?
SPE2DR26FSBZ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FSBZ8 worth?
The government has obligated $83,295 on SPE2DR26FSBZ8.
Is contract SPE2DR26FSBZ8 an order under another contract?
Yes. SPE2DR26FSBZ8 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSBZ8 competed?
The extent of competition for SPE2DR26FSBZ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award